It’s a situation that can understandably cause a ripple of concern: a medical device you rely on for managing your health is being withdrawn from the market. For individuals using the Alere INRatio PT/INR monitor system, this has been the reality. This system, which includes the INRatio or INRatio 2 monitors and their associated test strips, has been a tool for many, particularly those on anticoagulant medications like warfarin, to keep a close eye on their blood clotting ability.
Why the Change?
The core of the issue, as detailed in advisories, stems from a potential for the Alere INRatio PT/INR monitoring systems to sometimes provide an INR result that is clinically significantly lower than what a laboratory test would show. This discrepancy, while not always occurring, could happen under specific circumstances, such as if a patient has certain medical conditions or if the device's instructions aren't precisely followed. The implications of an inaccurately low INR reading can be serious, potentially leading to delays in necessary actions to manage high INR levels, or worse, no action being taken at all when it's critically needed.
While efforts were made to mitigate these risks, including software updates and revised instructions, these measures weren't deemed sufficient to fully address the identified concerns. Consequently, the decision was made, in consultation with regulatory bodies like the TGA, to withdraw the device from the market.
What This Means for You
Alere has been working to ensure a smooth transition for patients and healthcare professionals. They've continued manufacturing and distributing test strips for a period, giving everyone a window to find an alternative monitoring method. The most crucial advice here is to connect with your health professional as soon as possible. They are your best resource for discussing your specific situation and beginning the process of moving to a different PT/INR testing method.
Until you've made the switch, you're advised to continue using your Alere INRatio system, but with a heightened awareness. Keep in mind the potential for incorrect results, especially if you have specific medical conditions or if instructions aren't meticulously followed. It's also a good idea, as recommended, to have periodic verification of your INR using a laboratory method. This can help ensure your anticoagulation therapy remains appropriately adjusted.
Moving Forward
This recall isn't just about a product being removed; it's about ensuring continued safe and effective management of your health. The process of transitioning to a new monitoring system might seem daunting, but remember you're not alone. Your healthcare provider is there to guide you, and Alere has provided contact information for those with questions or concerns. Taking proactive steps now, by speaking with your doctor, is the most important move you can make. It’s about staying informed, staying connected with your medical team, and ensuring your health monitoring continues without interruption or compromise.
